Deargen was selected for the TIPS program, so it will receive a total of $600,000 in R & D expenses from the operator Medytox Venture Investment.
Read More
Technical & News Articles about Deargen
Deargen was selected for the TIPS program, so it will receive a total of $600,000 in R & D expenses from the operator Medytox Venture Investment.
Read MoreDeargen launches a beta service of ‘DearTRANS’ that is a cloud-based genomic big data analysis platform that the world’s first artificial intelligence technologies are applied.
Read MoreDeargen has been selected for the 2017 National Program for Cancer Control that is hosted by the Ministry of Health and Welfare and the National Cancer Center. Deargen will develop an integrated prognostic analysis model of lung cancer using artificial intelligence by collaboration with St. Mary’s Hospital and Dankook University.
Read MoreDeargen was selected as a Top Performer of the NCI-CPTAC DREAM Proteogenomics Computational Challenges that is international Challenges for cancer proteome prediction. Details of the challenge will be published in the Nature Method.
Read MoreDeargen was voted in the top 10 in the world at the ‘ImageNet Large Scale Visual Recognition Challenge (ILSVRC) 2016’, the Image Recognition International Competition. The error rate of 3.5% in recognition (the 4% human error rate) has attained, which shows a much improved result compared to the error rate of Microsoft Research Lab that is a last year’s winner.
Read More